Fernanda Sarahí Fajardo-Espinoza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fernanda Sarahí Fajardo-Espinoza has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Marlid Cruz-Ramos
Instituto Nacional de Cancerología Departamento de Oncología Médica de Mama ; Mexico City
3 shared publications - Sara Aileen Cabrera-Nieto
Facultad de Ciencias de la Salud, Universidad Anáhuac México, Huixquilucan, Mexico
3 shared publications A Romero-Rojas
Facultad de Estudios Superiores Cuautitlán Universidad Nacional Autónoma de México Carretera Cuautitlán-Teoloyucan Km. 2.5 CP 54714 Cuautitlán Izcalli México
1 shared publicationAimée C. Madariaga-Cobos
Faculty of Health Sciences, Universidad Anahuac Mexico, Mexico
1 shared publicationAlejandra Platas
Physicians and Researchers in the Fight Against Breast Cancer, Centro Oncológico, Hospital Ángeles Acoxpa, Mexico City, Mexico
1 shared publicationAlejandro Mohar
Unidad de Epidemiología e Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, UNAM-Instituto Nacional de Cancerología, Mexico City, Mexico
1 shared publication
Latest Publications
- Open Access
- 14 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12209
The Role of Adenosine in Overcoming Resistance in Sarcomas
Resistance to systemic therapies in sarcomas poses a significant challenge to improving clinical outcomes. Recent research has concentrated on the tumor microenvironment’s role in sarcoma progression and treatment resistance. This microenvironment comprises a variety of cell types and signaling molecules that influence tumor behavior, including proliferation, metastasis, and resistance to therapy. Adenosine, abundant in the tumor microenvironment, has been implicated in promoting immunosuppression and chemoresistance. Targeting adenosine receptors and associated pathways offers a novel approach to enhancing immune responses against tumors, potentially improving immunotherapy outcomes in cancers, including sarcomas. Manipulating adenosine signaling also shows promise in overcoming chemotherapy resistance in these tumors. Clinical trials investigating adenosine receptor antagonists in sarcomas have fueled interest in this pathway for sarcoma treatment. Ultimately, a comprehensive understanding of the tumor and vascular microenvironments, as well as the adenosine pathway, may open new avenues for improving treatment outcomes and overcoming resistance in sarcoma. Further studies and clinical trials are crucial to validate these findings and optimize therapeutic strategies, particularly for osteosarcoma. This study provides a literature review exploring the potential role of the adenosine pathway in sarcomas.
- 14 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12209
Open AccessThe Role of Adenosine in Overcoming Resistance in Sarcomas
Resistance to systemic therapies in sarcomas poses a significant challenge to improving clinical outcomes. Recent research has concentrated on the tumor microenvironment’s role in sarcoma progression and treatment resistance. This microenvironment comprises a variety of cell types and signaling molecules that influence tumor behavior, including proliferation, metastasis, and resistance to therapy. Adenosine, abundant in the tumor microenvironment, has been implicated in promoting immunosuppression and chemoresistance. Targeting adenosine receptors and associated pathways offers a novel approach to enhancing immune responses against tumors, potentially improving immunotherapy outcomes in cancers, including sarcomas. Manipulating adenosine signaling also shows promise in overcoming chemotherapy resistance in these tumors. Clinical trials investigating adenosine receptor antagonists in sarcomas have fueled interest in this pathway for sarcoma treatment. Ultimately, a comprehensive understanding of the tumor and vascular microenvironments, as well as the adenosine pathway, may open new avenues for improving treatment outcomes and overcoming resistance in sarcoma. Further studies and clinical trials are crucial to validate these findings and optimize therapeutic strategies, particularly for osteosarcoma. This study provides a literature review exploring the potential role of the adenosine pathway in sarcomas.
- Open Access
- 2 November 2023
- Published by Elsevier in Clinical Nutrition Open Science
- Vol. 52, 160-171
Effects of a high-protein diet and calcium caseinate supplementation on satiety perception and weight in Children with overweight and obesity: a randomized clinical trial
- 2 November 2023
- Published by Elsevier in Clinical Nutrition Open Science
- Vol. 52, 160-171
Open AccessEffects of a high-protein diet and calcium caseinate supplementation on satiety perception and weight in Children with overweight and obesity: a randomized clinical trial
- 8 August 2020
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 56 (5) , 2109-2121
In vitro cytomodulatory and immunomodulatory effects of bovine colostrum whey protein hydrolysates
Summary: Bovine colostrum possesses biological compounds involved in the development of the newborn. Among them, the proteins have drawn attention as a source of bioactive peptides. This study shows the in vitro cytotoxic and immunostimulatory potential of two colostrum whey protein (CWP) hydrolysates obtained by in vitro digestion with pepsin and pancreatin. MTT cell viability, apoptosis induction, polymorphonuclear proliferation and phagocytic activity assays were performed. Treatment with the hydrolysates induced a significant decrease in the viability of MDA‐MB‐231 cell lines due to apoptosis and also a significant increase in the proliferation of blood mononuclear cells. It could also be observed that for the RM‐1 and PC‐3 prostate cancer cell lines and for the two times of exposure (24 and 48 h), the hydrolysate H1 is significantly more cytotoxic than CWP. These results showed the potential of bovine CWP and its hydrolysates for the treatment of chronic diseases such as cancer.
- 8 August 2020
- Published by Oxford University Press (OUP) in International Journal of Food Science and Technology
- Vol. 56 (5) , 2109-2121
In vitro cytomodulatory and immunomodulatory effects of bovine colostrum whey protein hydrolysates
Summary: Bovine colostrum possesses biological compounds involved in the development of the newborn. Among them, the proteins have drawn attention as a source of bioactive peptides. This study shows the in vitro cytotoxic and immunostimulatory potential of two colostrum whey protein (CWP) hydrolysates obtained by in vitro digestion with pepsin and pancreatin. MTT cell viability, apoptosis induction, polymorphonuclear proliferation and phagocytic activity assays were performed. Treatment with the hydrolysates induced a significant decrease in the viability of MDA‐MB‐231 cell lines due to apoptosis and also a significant increase in the proliferation of blood mononuclear cells. It could also be observed that for the RM‐1 and PC‐3 prostate cancer cell lines and for the two times of exposure (24 and 48 h), the hydrolysate H1 is significantly more cytotoxic than CWP. These results showed the potential of bovine CWP and its hydrolysates for the treatment of chronic diseases such as cancer.
- Open Access
- 1 August 2019
- Published by Universidad Autonoma Metropolitana in Revista Mexicana de Ingeniería Química
- Vol. 19 (1) , 1-9
PRODUCTION OF BIOACTIVE PEPTIDES FROM BOVINE COLOSTRUM WHEY USING ENZYMATIC HYDROLYSIS
Bovine colostrum is an important source of nutritional and immunological factors that are vital for the early development and protection of the newborn. The aim of this study was to evaluate the antioxidant, mineral-binding (iron and calcium), and angiotensin-converting enzyme (ACE) inhibitory properties of the peptides generated through the enzymatic hydrolysis of bovine colostrum whey proteins. The whey proteins were hydrolyzed with pepsin at two pH values (1.3 and 2), and in a sequential hydrolysis system with pepsin and pancreatin. The hydrolysates were separated by ultrafiltration in three fractions with molecular weights of less than 10, from 10 to 30, and more than 30 kDa. The antioxidant and calcium binding activities increased with the hydrolysis and the highest values were obtained in the case of the fractions with less than 10 kDa. The fractions with molecular weights higher than 30 kDa had the best iron binding capacity. A high positive correlation (R=0.9669) was obtained between the degree of hydrolysis and the ACE inhibitory activity. El calostro bovino es una importante fuente de factores inmunológicos y nutricionales que son vitales para el desarrollo y protección de la cría. En el presente estudio se prepararon hidrolizados de proteína de suero de calostro bovino usando pepsina a dos valores de pH (1.3 y 2) y también en hidrólisis secuencial con pancreatina. Los hidrolizados se separaron por ultrafiltración para obtener 3 fracciones de distintos pesos moleculares (>30kDa, 10-30 kDa y <10kDa) para ser analizadas como fuente de péptidos con actividad antioxidante, quelante de minerales (hierro y calcio) e inhibidora de la enzima convertidora de angiotensina (ECA). Se observó un aumento en la actividad antioxidante y quelante de calcio de los hidrolizados, principalmente en las fracciones de peso molecular 30kDa. Se observó una alta correlación positiva (R=0.9669) entre el grado de hidrólisis (mEq. Leucina) y la actividad inhibidora de la ECA.
- 1 August 2019
- Published by Universidad Autonoma Metropolitana in Revista Mexicana de Ingeniería Química
- Vol. 19 (1) , 1-9
Open AccessPRODUCTION OF BIOACTIVE PEPTIDES FROM BOVINE COLOSTRUM WHEY USING ENZYMATIC HYDROLYSIS
Bovine colostrum is an important source of nutritional and immunological factors that are vital for the early development and protection of the newborn. The aim of this study was to evaluate the antioxidant, mineral-binding (iron and calcium), and angiotensin-converting enzyme (ACE) inhibitory properties of the peptides generated through the enzymatic hydrolysis of bovine colostrum whey proteins. The whey proteins were hydrolyzed with pepsin at two pH values (1.3 and 2), and in a sequential hydrolysis system with pepsin and pancreatin. The hydrolysates were separated by ultrafiltration in three fractions with molecular weights of less than 10, from 10 to 30, and more than 30 kDa. The antioxidant and calcium binding activities increased with the hydrolysis and the highest values were obtained in the case of the fractions with less than 10 kDa. The fractions with molecular weights higher than 30 kDa had the best iron binding capacity. A high positive correlation (R=0.9669) was obtained between the degree of hydrolysis and the ACE inhibitory activity. El calostro bovino es una importante fuente de factores inmunológicos y nutricionales que son vitales para el desarrollo y protección de la cría. En el presente estudio se prepararon hidrolizados de proteína de suero de calostro bovino usando pepsina a dos valores de pH (1.3 y 2) y también en hidrólisis secuencial con pancreatina. Los hidrolizados se separaron por ultrafiltración para obtener 3 fracciones de distintos pesos moleculares (>30kDa, 10-30 kDa y <10kDa) para ser analizadas como fuente de péptidos con actividad antioxidante, quelante de minerales (hierro y calcio) e inhibidora de la enzima convertidora de angiotensina (ECA). Se observó un aumento en la actividad antioxidante y quelante de calcio de los hidrolizados, principalmente en las fracciones de peso molecular 30kDa. Se observó una alta correlación positiva (R=0.9669) entre el grado de hidrólisis (mEq. Leucina) y la actividad inhibidora de la ECA.